Jinhai Medical Technology forecasts increased first-half loss

Jinhai Medical Technology Limited has issued a profit warning, anticipating a net loss after taxation of approximately S$10.8 million for the six months ended June 30, 2025 (1H2025). This represents a substantial increase compared to the S$6.0 million net loss reported for the same period in 2024 (1H2024).

The widened loss for 1H2025 is primarily attributed to a decrease in the group's gross profit, estimated at approximately S$5 million. This decline in gross profit stems from reduced revenue generated by the group's business operations, specifically in minimally invasive surgery solutions, medical products, related services, and dormitory services.

The company emphasizes that this announcement is based on a preliminary assessment of unaudited consolidated management accounts for 1H2025 and is subject to adjustment. The interim unaudited consolidated financial results for 1H2025 are expected to be officially published in August 2025.